New silver solution proves effective in killing MRSA

A breakthrough independent lab study has determined the efficacy of a new antimicrobial silver solution in killing antibiotic-resistant bacteria is significantly higher than many other silver products.

Richard A. Robison, PhD, professor of microbiology, immunology and bacterial pathogenesis at Brigham Young University in Provo, Utah, tested five silver products against methicillin-resistant Staphylococcus aureus, giving each product two minutes of contact time with the bacteria.

An antimicrobial silver solution named Advanced Cellular Silver 200 killed MRSA at a rate of 99.99 percent and was 4,000 to 1 million times more effective than the four other silver products tested.

ACS 200 is an antimicrobial silver solution oral spray that is taken with antibiotics to boost the drug's strength and kill antibiotic-resistant bacteria

ACS 200's efficacy can be attributed to its formulation, which has uniquely energized silver molecules to kill deadly microorganisms such as MRSA in record time.

The breakthrough results could be very impactful to enhancing and extending the efficacy of antibiotics and preventing resistance.



More articles on MRSA:
FDA provides clearance for Roche MRSA/SA test
Pulsed xenon UV light kills C. diff and MRSA in hospital rooms, study finds
Healthcare-associated MRSA infections increase mortality risk

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars